Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies
- PMID: 23507484
- DOI: 10.1053/j.seminhematol.2013.01.004
Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies
Abstract
The recent identification of covalent cytosine modifications derived from the metabolism of 5-methylcytosine (5-mC) and catalyzed by the TET proteins has facilitated molecular insight into a new subclass of acute myeloid leukemias (AMLs). TET2-mutant AMLs have the predicted hypermethylation phenotype expected given the inability of the mutant TET2 protein to convert 5-mC to 5-hydroxymethylcytosine (5-hmC). In addition, IDH1/2 mutations confer a gain-of-function, allowing the enzymes to process α-ketoglutarate to 2-hydroxyglutarate, which inhibits the TET proteins and ultimately induces the same hypermethylation phenotype. New techniques are being developed rapidly that have the unprecedented capacity to distinguish among the various covalent cytosine modifications now known to exist. Soon, these methods will be harnessed to yield a new level of insight into AMLs with altered distribution of 5-hmC, information that may allow new diagnostic and therapeutic approaches for patients with this subtype of AML.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
The TET2 interactors and their links to hematological malignancies.IUBMB Life. 2015 Jun;67(6):438-45. doi: 10.1002/iub.1389. Epub 2015 Jun 22. IUBMB Life. 2015. PMID: 26099018 Free PMC article. Review.
-
Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.Oncol Res Treat. 2019;42(6):309-318. doi: 10.1159/000498947. Epub 2019 May 3. Oncol Res Treat. 2019. PMID: 31055566 Review.
-
Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.J Biol Chem. 2013 May 10;288(19):13669-74. doi: 10.1074/jbc.C113.464800. Epub 2013 Apr 2. J Biol Chem. 2013. PMID: 23548903 Free PMC article.
-
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.Cell. 2012 Sep 14;150(6):1135-46. doi: 10.1016/j.cell.2012.07.033. Cell. 2012. PMID: 22980977 Free PMC article.
-
Research Advances in the Mutation of TET2 Gene in Myeloid Maligancies.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Oct 10;38(5):583-588. doi: 10.3881/j.issn.1000-503X.2016.05.017. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 27825418 Review.
Cited by
-
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis.Cell Rep. 2014 Jan 16;6(1):231-244. doi: 10.1016/j.celrep.2013.11.044. Epub 2013 Dec 27. Cell Rep. 2014. PMID: 24373966 Free PMC article.
-
5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia.Oncotarget. 2017 Jan 31;8(5):8305-8314. doi: 10.18632/oncotarget.14171. Oncotarget. 2017. PMID: 28039446 Free PMC article.
-
Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes.Int J Mol Sci. 2022 Dec 16;23(24):16069. doi: 10.3390/ijms232416069. Int J Mol Sci. 2022. PMID: 36555712 Free PMC article. Review.
-
Hydroxymethylcytosine and demethylation of the γ-globin gene promoter during erythroid differentiation.Epigenetics. 2015;10(5):397-407. doi: 10.1080/15592294.2015.1039220. Epigenetics. 2015. PMID: 25932923 Free PMC article.
-
New themes in the biological functions of 5-methylcytosine and 5-hydroxymethylcytosine.Immunol Rev. 2015 Jan;263(1):36-49. doi: 10.1111/imr.12242. Immunol Rev. 2015. PMID: 25510270 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous